Data Analysis
The process of data collection includes such stages as preparation, representation, and analysis. Moreover, adults over 65 years old choose polypharmacy because it prevents the risks of chronic diseases for them. The benefit of it is a thorough estimation of prescribed medication and its implication in finding the preventive tactics in the healthcare system. The education about polypharmacy is a scarcity in resources and their results in business. With polypharmacy, it is possible to measure and track the incidence rates and their prevalence in society. Therefore, data collection determines the opportunity to develop and assess the situation from different angles.
We can write a research on Polypharmacy for you!
The process of finding results contains a valuable set of question, which intend to increase the value in the research. The evidence-based practice (EBP) determines that people over 65 years old have exposure for drug-related medicine, which is 11,7 percent (Morin, Johnell, Laroche, Fastbom & Wastesson, 2018). It describes an opportunity to develop and maintain a practical reason about solving the case and determining the problem about its maintenance. The stakeholders for the research are patients, physicians, and pharmaceutical companies. In effect, they will take part in the open-ended questionnaire for data collection about the research problem. Hence, such a process ensures effective instrument for solving the problem and defining its reasons about success and representation in business.
The conditions that require polypharmacy are overprescribed medicine, drug interaction, and morbidity. The PICOT question about 65 years old adults represents how educational level influences the process of taking the medication in society: what is people over 65 years old (P) might benefit from prescribed medication (I) in comparison with those who take it (C) and how polypharmacy can reduce it (O) in the next three years (T)? Respondents might mention the effective strategies about long-term conditions and their approaches to launching strategy about educational concerns and their use for patients. In this regard, polypharmacy is an essential problem for the healthcare system in the world. As a result, the ability to improve the sufficient progress about scope and time in the process of improving the outcomes about medical complexities.
The quantitative method of the questionnaire is for the mentioned research. In essence, it has open-ended questions about polypharmacy and its use in healthcare. The ability to represent the evidence-based information (EBI) describes an essential consequence for education concerns and their results in society. People aged over 65 years old describe a vital opportunity to declare methods and illustrate the prominent values about diseases and their influence on a person in this case. About 5 percent of them suffer from polypharmacy (Dhalwani et al., 2017). The educational factor plays a crucial role in the process of ensuring and developing the framework about success and its representation in society. The data collection will occur after signing the consent about the results. In addition, respondents should answer and estimate the necessary feedback about the questionnaire and its consequences in the healthcare system. The analysis will require SPSS program, which measures the correlations between respondents and their results. Hence, a quantitative method with open-ended questions is a vital instrument for designing the task for exploring the problem of explaining the reasons in the healthcare system.
The research is experimental, and it has the following points as interventional and observational studies, which are ten in total as a number. Furthermore, START criteria determine the solution about effective strategy and its representation of polypharmacy and how it influences health. The educational aspect changes the way of taking drugs and their implications about use and image in estimating the program about effective strategy in society. The necessity to determine the critical impact of success and its representation in finding medications in the healthcare industry. Thus, the experimental research illustrates the efficacy of the results of polypharmacy.
The length of the data collection will require three months. It describes the necessity to measure the results and determine their significance. The snowball sampling explains that availability is the main criterium for the investigation. The obligation to define and declare the needs is an essential step for classifying the practical reasons about efficiency in the research. The medication, which people aged over 65 years old, relates to medical representation and its alternatives about chronic disease, as 12,8 percent of them have the mentioned problem (Charlesworth, Smit, Lee, Alramadhan & Odden, 2015). Such a description introduces a fundamental principle of the investigation about polypharmacy. Hence, data length collection implements an essential approach to estimate and measure the effectiveness at the national level.
The used resources are experimental and refer to MAI criterium, which is post-interventional in this case. Such a description opens a new way of explaining four articles as the main implications for solving the issue with the experiments (Sirois et al., 2017). The other resources refer to START criteria because they develop a meaningful approach about success and its implication in business representation. The necessity to estimate the risks is an essential task for creating the opportunity to build and ensure the effectiveness in polypharmacy. Thus, the resources represent a significant opportunity to develop and estimate the risks of polypharmacy and its consequences in studies.
The GRADE and START are the additional methods, which intend to estimate the research and its materials. Moreover, polypharmacy introduces a basic norm about success and its mortality risks in the healthcare system (Rieckert et al., 2018). The GRADE rubric includes grades of recommendation, assessment development, development, and evaluation. They determine how various stakeholders, including pharmaceutical companies, patients, and physicians can react towards pathological changes in the system. In addition, START criteria represent a significant opportunity to develop and estimate the possible risks about effective strategy and its improvement in the system. The mentioned methods aim to increase the tasks and outline their critical implications about polypharmacy and its use (Ersoy & Engin, 2018). It describes daily drug consumption, and people over 65 years old should decrease its results in the system. The setting and sampling are the essential data collection methods for the research. Nearly 30 percent of people over 65 years old represents the issue of polypharmacy and how it influences their health in society (Kim & Parish, 2017). Such a value opens a new way of improving data collection in the process. Thus, the illustrated standards represent a valuable approach to develop a meaningful instrument for increasing competitive performance in healthcare.
Analysis. The data analysis comprises a clustering method for its synthesis. It means that patients, doctors, and pharmaceutical companies might have different categories of their representation in business. About 56 percent of people over 65 years old have polypharmacy in their lives (Chan, Chen, Wen, Chiu & Wu, 2014). It increases the value of the system and how it represents a useful overview of the problem of success and its representation in society. Such EBI describes why patients should cope with their problems and develop them thoroughly. Its success implies a significant opportunity to measure and track the interferential statistics of standard deviation. Since the central hypothesis is that people over 65 years old receive enough information about polypharmacy, it explains an essential direction about success and its improvement in the research. Its significance represents a significant result of standard deviation and its development in a scientific framework. The results describe the importance of measuring the effectiveness of education in healthcare centers. In this regard, such an opportunity implies an important direction about success and its implication in business. Hence, standard deviation is an important statistical method for creating the positive overvire of the results in the research.
Evaluation
Polypharmacy is an adverse effect on health improvement for older adults. For pharmaceutical companies, the possible outcomes are multiple uses of frugs and their decrease in the market. The patients should obtain the proper access to resources and their chances to have a high service at a healthcare institution. In essence, physicians represent a valuable asset in treating people and estimating their health status correctly. The EBP proposal is active because about 40,6 percent of older people have the experience of using multiple medications at the same time (Golchin, Frank, Ishlam & Meropol, 2015). The critical suggestions for the mentioned alternative are an improvement in the liability services and their launch in healthcare institutions and education opportunities for the medical personnel. The pharmaceutical area is possible for implementing its results in business. Therefore, the EBP area determines an essential solution about solving the analytical methods about success and development in the healthcare industry.
Dissemination of Results
The results abuot polypharmacy and its decrease can influence the mentioned stakeholders in the following ways:
Patients: About 25,4 percent of patients can have polypharmacy (Golchin, Frank, Ishlam & Meropol, 2015). Such an indicator defines the role in business and its processes in management and how it can influence the management system in the market.
Pharmaceutical companies: The decrease of polypharmacy can create a downturining line in their profits and, as a result, it might cause financial losses for them. The hypothetical result is 20 percent in this section.
Physicians: The communication improvement is evident for patients and its representation enlarges a particular scope in solving disputes and problems about polypharmacy.
The national levels will influence pharmacy and medicine because such sectors define an important role for improving business and its profits in the world. The facility area concerns medication and its dissemination in hospitals, while the state can benefit from it.
Conclusion
To conclude, polypharmacy is a severe problem for people aged over 65 years old because it launches a new opportunity to define and restructure the medicine. Moreover, the potential contributions to EBP proposal are efficient launch and significant development in the system. The ability to indicate the tasks is a vital norm for increasing the functions and their objectives in business. As a consequence, the mentioned representation implies a significant opportunity to develop and maintain the essential standards in the healthcare sector on a global scale.
EffectivePapers.com is a professional academic paper writing service committed to writing non-plagiarized custom research papers of top quality. All academic papers are written from scratch by highly qualified research paper writers you can hire online. Just proceed with your order, and we will find the best expert for you!
References
Chan, D., Chen, J., Wen, C., Chiu, L., & Wu, S. (2014). Effectiveness of the medication safety review clinics for older adults prescribed multiple medications. Journal Of The Formosan Medical Association, 113(2), 106-113. doi: 10.1016/j.jfma.2012.04.013
Charlesworth, C., Smit, E., Lee, D., Alramadhan, F., & Odden, M. (2015). Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988–2010. The Journals Of Gerontology Series A: Biological Sciences And Medical Sciences, 70(8), 989-995. doi: 10.1093/gerona/glv013
Dhalwani, N., Fahami, R., Sathanapally, H., Seidu, S., Davies, M., & Khunti, K. (2017). Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open, 7(10). doi: 10.1136/bmjopen-2017-016358
Dhalwani, N., Fahami, R., Sathanapally, H., Seidu, S., Davies, M., & Khunti, K. (2017). Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open, 7(10). doi: 10.1136/bmjopen-2017-016358
Ersoy, S., & Engin, V. (2018). Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study. Clinical Interventions In Aging, Volume 13, 2003-2011. doi: 10.2147/cia.s176329
Golchin, N., Frank, S., Ishlam, L., & Meropol, S. (2015). Polypharmacy in the elderly. J. Res. Pharm. Practice, 4(2).
Kim, J., & Parish, A. (2017). Polypharmacy and Medication Management in Older Adults. Nursing Clinics Of North America, 52(3), 457-468. doi: 10.1016/j.cnur.2017.04.007
Morin, L., Johnell, K., Laroche, M., Fastbom, J., & Wastesson, J. (2018). The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clinical Epidemiology, Volume 10, 289-298. doi: 10.2147/clep.s153458
Rieckert, A., Trampisch, U., Klaaßen-Mielke, R., Drewelow, E., Esmail, A., & Johansson, T. et al. (2018). Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC Family Practice, 19(1). doi: 10.1186/s12875-018-0795-5
Sirois, C., Laroche, M., Guénette, L., Kröger, E., Cooper, D., & Émond, V. (2017). Polypharmacy in multimorbid older adults: protocol for a systematic review. Systematic Reviews, 6(1). doi: 10.1186/s13643-017-0492-9
Wallace, J., & Paauw, D. (2015). Appropriate Prescribing and Important Drug Interactions in Older Adults. Medical Clinics Of North America, 99(2), 295-310. doi: 10.1016/j.mcna.2014.11.005